WallStreetZenWallStreetZen

NASDAQ: KNSA
Kiniksa Pharmaceuticals Ltd Stock

Open Broker Account
$13.81-0.42 (-2.95%)
Updated Oct 5, 2022
KNSA Price
$13.81
Fair Value Price
$14.73
Market Cap
$959.40M
52 Week Low
$7.36
52 Week High
$15.25
P/E
-8.58x
P/B
6.25x
P/S
7.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$90.00M
Earnings
-$112.07M
Gross Margin
82.4%
Operating Margin
-121.41%
Profit Margin
-124.5%
Debt to Equity
0.37
Operating Cash Flow
-$92M
Beta
1.04
Next Earnings
Oct 31, 2022
Ex-Dividend
N/A
Next Dividend
N/A

KNSA Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how KNSA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

KNSA ($13.81) is undervalued by 6.22% relative to our estimate of its Fair Value price of $14.73 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
KNSA ($13.81) is not significantly undervalued (6.22%) relative to our estimate of its Fair Value price of $14.73 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
KNSA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more KNSA due diligence checks available for Premium users.

Be the first to know about important KNSA news, forecast changes, insider trades & much more!

KNSA News

Valuation

KNSA fair value

Fair Value of KNSA stock based on Discounted Cash Flow (DCF)
Price
$13.81
Fair Value
$14.73
Undervalued by
6.22%
KNSA ($13.81) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
KNSA ($13.81) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
KNSA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

KNSA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-8.58x
Industry
16.06x
Market
28.61x

KNSA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.25x
Industry
4.51x
KNSA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

KNSA's financial health

Profit margin

Revenue
$27.0M
Net Income
-$20.0M
Profit Margin
-74.1%
KNSA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
KNSA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$210.6M
Liabilities
$57.1M
Debt to equity
0.37
KNSA's short-term assets ($179.94M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KNSA's short-term assets ($179.94M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KNSA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.8M
Investing
$38.3M
Financing
$542.0k
KNSA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

KNSA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
KNSA$959.40M-2.95%-8.58x6.25x
FMTX$955.14M0.00%-5.00x2.30x
COGT$953.49M-2.29%-5.82x2.99x
KURA$947.87M+3.36%-7.05x2.11x
IGMS$941.44M-3.33%-3.89x2.51x

Kiniksa Pharmaceuticals Stock FAQ

What is Kiniksa Pharmaceuticals's quote symbol?

NASDAQ: KNSA) Kiniksa Pharmaceuticals trades on the NASDAQ under the ticker symbol KNSA. Kiniksa Pharmaceuticals stock quotes can also be displayed as NASDAQ: KNSA.

If you're new to stock investing, here's how to buy Kiniksa Pharmaceuticals stock.

What is the 52 week high and low for Kiniksa Pharmaceuticals (NASDAQ: KNSA)?

(NASDAQ: KNSA) Kiniksa Pharmaceuticals's 52-week high was $15.25, and its 52-week low was $7.36. It is currently -9.41% from its 52-week high and 87.64% from its 52-week low.

How much is Kiniksa Pharmaceuticals stock worth today?

(NASDAQ: KNSA) Kiniksa Pharmaceuticals currently has 69,471,099 outstanding shares. With Kiniksa Pharmaceuticals stock trading at $13.81 per share, the total value of Kiniksa Pharmaceuticals stock (market capitalization) is $959.40M.

Kiniksa Pharmaceuticals stock was originally listed at a price of $19.47 in May 24, 2018. If you had invested in Kiniksa Pharmaceuticals stock at $19.47, your return over the last 4 years would have been -29.07%, for an annualized return of -8.23% (not including any dividends or dividend reinvestments).

How much is Kiniksa Pharmaceuticals's stock price per share?

(NASDAQ: KNSA) Kiniksa Pharmaceuticals stock price per share is $13.81 today (as of Oct 5, 2022).

What is Kiniksa Pharmaceuticals's Market Cap?

(NASDAQ: KNSA) Kiniksa Pharmaceuticals's market cap is $959.40M, as of Oct 6, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Kiniksa Pharmaceuticals's market cap is calculated by multiplying KNSA's current stock price of $13.81 by KNSA's total outstanding shares of 69,471,099.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.